Category: Targeting Ligands

Aptamer Structural Motifs and Engineering Strategies for Improved Affinity and Stability Introduction Aptamers are short single-stranded DNA or RNA molecules that fold into defined three-dimensional structures and recognize targets with high affinity and specificity. Generated through SELEX (Systematic Evolution of Ligands by Exponential Enrichment), aptamers offer advantages including chemical synthesis, precise modification, small molecular size, …

Optimizing SELEX Stringency Conditions for High-Affinity Aptamer Selection Introduction SELEX (Systematic Evolution of Ligands by Exponential Enrichment) is the most widely used platform for identifying high-affinity aptamers from large nucleic acid libraries. Through repeated cycles of binding, separation, and amplification, SELEX enables the enrichment of DNA aptamers and RNA aptamers with strong target recognition. A …

Synthetic Quality Control: Ensuring Reliable Peptide Library Services for Drug Discovery Introduction Peptide libraries are essential tools in drug discovery, enabling high-throughput screening of numerous sequences. However, their scientific value depends entirely on construction precision. Synthetic quality control (QC) serves as the critical foundation, ensuring downstream data is accurate and reproducible. Core Elements of Quality-Driven …

Aptamers vs. Antibodies: The Next Generation of Diagnostic Tools Introduction Monoclonal antibodies have long been the foundation of diagnostic testing, but their limitations—thermal instability, batch variability, and high production costs—are driving the search for better alternatives. Aptamers, short single-stranded oligonucleotides often called “chemical antibodies,” offer a synthetic solution. Through chemical synthesis rather than biological expression, …

The SELEX Process: A Guide to DNA and RNA Aptamer Selection Introduction Aptamers are single-stranded oligonucleotides that fold into unique 3D structures to bind targets with high specificity. Often called “chemical antibodies,” they offer advantages over traditional protein binders. These molecules are discovered through SELEX (Systematic Evolution of Ligands by Exponential Enrichment), an iterative in …

SELEX Technology: Expert Guide to Choosing Between RNA and DNA Aptamers Overview of SELEX Technology Systematic Evolution of Ligands by EXponential enrichment (SELEX) is the gold-standard in vitro process for screening nucleic acid aptamers. This technology operates by cycling through “incubation-separation-amplification” steps to isolate high-affinity sequences from massive libraries (10¹³–10¹⁵ variants). While SELEX offers superior …

Aptamer Design Strategies: A Complete Guide to RNA, Peptide, and Protein Aptamers for Biotech Innovation Aptamers are molecular recognition elements engineered through in vitro selection or rational design to bind targets such as proteins, small molecules, or cell receptors with high affinity and specificity. As a cornerstone of modern biotechnology, aptamer design spans nucleic acids, …

Decoding Protein Interactions: High-Throughput Peptide Library Screening for Drug Discovery Protein-protein interactions (PPIs) govern cellular communication and are prime targets for therapeutic intervention. Peptide library screening has emerged as a powerful, high-throughput strategy to dissect these interactions with precision. By systematically displaying thousands of peptide sequences, researchers can map binding epitopes, identify lead compounds, and …

Cell-SELEX for Aptamer Screening: Overcoming Target Purification Challenges in Drug Discovery Aptamers—single-stranded DNA or RNA ligands—offer key advantages over antibodies: chemical synthesis, low immunogenicity, and deep tissue penetration. However, traditional SELEX requires purified, soluble targets, which often misfold membrane proteins or strip essential post‑translational modifications. Cell‑SELEX solves this by using intact living cells, preserving native …

Cyclic vs. Linear Peptides: Key Differences, Design Strategies, and Screening for Drug Development Introduction In peptide-based drug development, cyclic and linear peptides represent two fundamental structural forms with distinct properties that impact their therapeutic potential. Cyclic peptides, with constrained closed-loop structures, offer enhanced metabolic stability and target affinity, making them promising for challenging targets and …